Immediate Impact
56 standout
Citing Papers
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
2025 Standout
Targeting KRAS: from metabolic regulation to cancer treatment
2025 Standout
Works of Liping Shu being referenced
Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Liping Shu | 210 | 54 | 32 | 112 | 86 | 38 | 590 | |
| He Huang | 224 | 70 | 29 | 46 | 23 | 39 | 734 | |
| Zofia Dzierżewicz | 331 | 58 | 55 | 88 | 43 | 68 | 739 | |
| Baiping Mao | 219 | 27 | 68 | 36 | 117 | 37 | 719 | |
| Li Kong | 210 | 73 | 14 | 113 | 22 | 25 | 676 | |
| Jae‐Ho Shin | 135 | 76 | 5 | 64 | 123 | 32 | 687 | |
| Jun Liu | 318 | 127 | 40 | 88 | 46 | 44 | 721 | |
| Yi Hua | 218 | 43 | 17 | 37 | 23 | 37 | 539 | |
| Mahshid Hodjat | 188 | 52 | 19 | 56 | 35 | 54 | 587 | |
| Zhiyong Hu | 306 | 38 | 34 | 177 | 59 | 36 | 610 | |
| Danyan Li | 137 | 39 | 5 | 37 | 28 | 49 | 598 |
All Works
Login with ORCID to disown or claim papers
Loading papers...